Form 4: WW International Director Awarded Deferred Stock Units

WW International Director Eugene I. Davis received an award of 1,219 Deferred Stock Units for his service on the Board of Directors.

Summary

• Eugene I. Davis, a Director of WW International, Inc. (WW), was granted 1,219 Deferred Stock Units (DSUs).
• The award was made on December 19, 2025, for his service as a Board member during the third quarter of fiscal 2025.
• Each DSU represents the right to receive one share of Common Stock upon settlement.
• The DSUs will be settled into shares of Common Stock upon Mr. Davis's separation from service from the Issuer's Board of Directors, as per the deferred compensation program for non-employee directors.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading plan.

Sentiment

Score: 6

Explanation: Neutral to slightly positive. The filing reports a routine compensation event for a director, which is a normal part of corporate operations and governance. It indicates stability in board compensation practices and aligns director interests with shareholders, but does not provide new material financial or operational news.

Positives

• The award of Deferred Stock Units aligns the director's interests with those of shareholders, as the value of the compensation is tied to the company's stock performance.
• This is a routine compensation for board service, indicating stable corporate governance practices and a structured approach to director remuneration.

Future Outlook

The Deferred Stock Units will be settled into shares of Common Stock on the date of Eugene I. Davis's separation from service from WW International's Board of Directors, as per the deferred compensation program.

Industry Context

The granting of Deferred Stock Units to non-employee directors is a common practice across various industries, including the health and wellness sector where WW International operates. This method of compensation is often used to attract and retain qualified board members while aligning their long-term interests with shareholder value.

Comparison to Industry Standards

• The use of Deferred Stock Units (DSUs) for non-employee director compensation is a standard practice, comparable to compensation structures seen at companies like Nutrisystem, Medifast, or other publicly traded health and wellness companies.
• The grant of equity-based compensation, rather than solely cash, is a widely adopted governance practice to foster long-term commitment and align director incentives with company performance, similar to practices at peer companies in the consumer health sector.

Corporate Governance

Stakeholder Impact

• Shareholders: The award of DSUs aligns the director's long-term interests with shareholder value, as the compensation's ultimate value depends on the company's stock performance.
• Board of Directors: This reflects the ongoing compensation structure for non-employee directors, which is designed to attract and retain qualified individuals.

Next Steps

• Settlement of the 1,219 Deferred Stock Units into shares of Common Stock upon Eugene I. Davis's separation from service from the Board of Directors.

Key Dates

Keywords

WW International, WW, Eugene I. Davis, Deferred Stock Units, DSU, Director Compensation, Insider Transaction, Form 4, Equity Award, Corporate Governance